Fig. 3

Assessment of IBS-SSS scores in participants by RH 3201. (A) Total IBS-SSS score. (B) Severity of abdominal bloating. (C) Dissatisfaction of bowel habits. (D) Interference with quality of life. Data were expressed as mean ± standard deviation. Significant differences compared to the placebo group are indicated as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001) using independent samples t-test.